JEMPERLI conc perf 500 mg/10ml amp 10 ml
7680680230015
CH-68023
L01FF07
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6802301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- dostarlimabum 500 mg, natrii citras dihydricus, acidum citricum monohydricum, arginini hydrochloridum, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 22.78 mg.
Articles (1)
Jemperli 500 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
dostarlimabum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
arginini hydrochloridum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
22.78 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 4846.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2022
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68023
- Drug name
- Jemperli, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FF07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/02/2022
- Authorization expiration date
- 21/12/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- JEMPERLI conc perf 500 mg/10ml amp 10 ml
- Description (DE)
- JEMPERLI Inf Konz 500 mg/10ml Amp 10 ml
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No